These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24867978)

  • 1. In vitro and in vivo evaluation of 28DAP010, a novel diamidine for treatment of second-stage African sleeping sickness.
    Wenzler T; Yang S; Patrick DA; Braissant O; Ismail MA; Tidwell RR; Boykin DW; Wang MZ; Brun R
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4452-63. PubMed ID: 24867978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis.
    Wenzler T; Yang S; Braissant O; Boykin DW; Brun R; Wang MZ
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5330-43. PubMed ID: 23959303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New treatment option for second-stage African sleeping sickness: in vitro and in vivo efficacy of aza analogs of DB289.
    Wenzler T; Boykin DW; Ismail MA; Hall JE; Tidwell RR; Brun R
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4185-92. PubMed ID: 19620327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.
    Nok AJ
    Parasitol Res; 2003 May; 90(1):71-9. PubMed ID: 12743807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic comparison to determine the mechanisms underlying the differential efficacies of cationic diamidines against first- and second-stage human African trypanosomiasis.
    Yang S; Wenzler T; Miller PN; Wu H; Boykin DW; Brun R; Wang MZ
    Antimicrob Agents Chemother; 2014 Jul; 58(7):4064-74. PubMed ID: 24798280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy of second stage human African trypanosomiasis: comparison between the parenteral diamidine DB829 and its oral prodrug DB868 in vervet monkeys.
    Thuita JK; Wolf KK; Murilla GA; Bridges AS; Boykin DW; Mutuku JN; Liu Q; Jones SK; Gem CO; Ching S; Tidwell RR; Wang MZ; Paine MF; Brun R
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003409. PubMed ID: 25654243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phenomenon of treatment failures in Human African Trypanosomiasis.
    Brun R; Schumacher R; Schmid C; Kunz C; Burri C
    Trop Med Int Health; 2001 Nov; 6(11):906-14. PubMed ID: 11703845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diamidines for human African trypanosomiasis.
    Paine MF; Wang MZ; Generaux CN; Boykin DW; Wilson WD; De Koning HP; Olson CA; Pohlig G; Burri C; Brun R; Murilla GA; Thuita JK; Barrett MP; Tidwell RR
    Curr Opin Investig Drugs; 2010 Aug; 11(8):876-83. PubMed ID: 20721830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melarsoprol sensitivity profile of Trypanosoma brucei gambiense isolates from cured and relapsed sleeping sickness patients from the Democratic Republic of the Congo.
    Pyana Pati P; Van Reet N; Mumba Ngoyi D; Ngay Lukusa I; Karhemere Bin Shamamba S; Büscher P
    PLoS Negl Trop Dis; 2014 Oct; 8(10):e3212. PubMed ID: 25275572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimerization at the AQP2-AQP3 locus is the genetic basis of melarsoprol-pentamidine cross-resistance in clinical Trypanosoma brucei gambiense isolates.
    Graf FE; Baker N; Munday JC; de Koning HP; Horn D; Mäser P
    Int J Parasitol Drugs Drug Resist; 2015 Aug; 5(2):65-8. PubMed ID: 26042196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ever-increasing complexities of diamidine and arsenical crossresistance in African trypanosomes.
    de Koning HP
    Trends Parasitol; 2008 Aug; 24(8):345-9. PubMed ID: 18599351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current chemotherapy of human African trypanosomiasis.
    Docampo R; Moreno SN
    Parasitol Res; 2003 Jun; 90 Supp 1():S10-3. PubMed ID: 12811544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aquaporin 2 mutations in Trypanosoma brucei gambiense field isolates correlate with decreased susceptibility to pentamidine and melarsoprol.
    Graf FE; Ludin P; Wenzler T; Kaiser M; Brun R; Pyana PP; Büscher P; de Koning HP; Horn D; Mäser P
    PLoS Negl Trop Dis; 2013; 7(10):e2475. PubMed ID: 24130910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug reformulation for a neglected disease. The NANOHAT project to develop a safer more effective sleeping sickness drug.
    Sanderson L; da Silva M; Sekhar GN; Brown RC; Burrell-Saward H; Fidanboylu M; Liu B; Dailey LA; Dreiss CA; Lorenz C; Christie M; Persaud SJ; Yardley V; Croft SL; Valero M; Thomas SA
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009276. PubMed ID: 33857146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target-based drug discovery for human African trypanosomiasis: selection of molecular target and chemical matter.
    Gilbert IH
    Parasitology; 2014 Jan; 141(1):28-36. PubMed ID: 23931634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypanocidal activity of dicationic compounds related to pentamidine.
    Donkor IO; Assefa H; Rattendi D; Lane S; Vargas M; Goldberg B; Bacchi C
    Eur J Med Chem; 2001 Jun; 36(6):531-8. PubMed ID: 11525843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy of human African trypanosomiasis.
    Burchmore RJ; Ogbunude PO; Enanga B; Barrett MP
    Curr Pharm Des; 2002; 8(4):256-67. PubMed ID: 11860365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The continuing problem of human African trypanosomiasis (sleeping sickness).
    Kennedy PG
    Ann Neurol; 2008 Aug; 64(2):116-26. PubMed ID: 18756506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Veterinary link to drug resistance in human African trypanosomiasis?
    Barrett MP
    Lancet; 2001 Aug; 358(9282):603-4. PubMed ID: 11530144
    [No Abstract]   [Full Text] [Related]  

  • 20. Positively selected modifications in the pore of TbAQP2 allow pentamidine to enter
    Alghamdi AH; Munday JC; Campagnaro GD; Gurvic D; Svensson F; Okpara CE; Kumar A; Quintana J; Martin Abril ME; Milić P; Watson L; Paape D; Settimo L; Dimitriou A; Wielinska J; Smart G; Anderson LF; Woodley CM; Kelly SPY; Ibrahim HM; Hulpia F; Al-Salabi MI; Eze AA; Sprenger T; Teka IA; Gudin S; Weyand S; Field M; Dardonville C; Tidwell RR; Carrington M; O'Neill P; Boykin DW; Zachariae U; De Koning HP
    Elife; 2020 Aug; 9():. PubMed ID: 32762841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.